Cargando…

The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India

There has been a surge of mucormycosis cases in India in the wake of the second wave of COVID-19 with more than 40000 cases reported. Mucormycosis in patients of COVID-19 in India is at variance to other countries where Aspergillus, Pneumocystis, and Candida have been reported to be the major second...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakrabarti, Sankha Shubhra, Kaur, Upinder, Aggarwal, Sushil Kumar, Kanakan, Ahalya, Saini, Adesh, Agrawal, Bimal Kumar, Jin, Kunlin, Chakrabarti, Sasanka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JKL International LLC 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782544/ https://www.ncbi.nlm.nih.gov/pubmed/35111359 http://dx.doi.org/10.14336/AD.2021.0811

Ejemplares similares

Case Report: Rhino-orbital Mucormycosis Related to COVID-19: A Case Series Exploring Risk Factors
por: Aggarwal, Sushil Kumar, et al.
Publicado: (2022)

Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India
por: Chakrabarti, Sasanka, et al.
Publicado: (2022)

Of Cross-immunity, Herd Immunity and Country-specific Plans: Experiences from COVID-19 in India
por: Chakrabarti, Sankha Shubhra, et al.
Publicado: (2020)

Oxidative Stress, Neuroinflammation, and NADPH Oxidase: Implications in the Pathogenesis and Treatment of Alzheimer's Disease
por: Ganguly, Upasana, et al.
Publicado: (2021)

Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
por: Ganguly, Upasana, et al.
Publicado: (2018)

Rapidly Progressive Dementia with Asymmetric Rigidity Following ChAdOx1 nCoV-19 Vaccination
por: Chakrabarti, Sankha Shubhra, et al.
Publicado: (2022)

COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?
por: Chakrabarti, Sankha Shubhra, et al.
Publicado: (2020)

Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2
por: Kaur, Upinder, et al.
Publicado: (2020)

Renin–angiotensin–aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis
por: Kaur, Upinder, et al.
Publicado: (2021)

APOE4 allele in north Indian elderly patients with dementia or late onset depression-a multiple-disease case control study
por: Misra, Anamika, et al.
Publicado: (2019)

Serum 24‐hydroxycholesterol in probable Alzheimer's dementia: Reexploring the significance of a tentative Alzheimer's disease biomarker
por: Roy, Debashree, et al.
Publicado: (2019)

Long-Term Safety Analysis of the ChAdOx1-nCoV-19 Corona Virus Vaccine: Results from a Prospective Observational Study in Priority Vaccinated Groups in North India
por: Kaur, Upinder, et al.
Publicado: (2023)

Epidemiology of Mucormycosis in India
por: Prakash, Hariprasath, et al.
Publicado: (2021)

A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India
por: Kaur, Upinder, et al.
Publicado: (2021)

Determinants of COVID-19 Breakthrough Infections and Severity in ChAdOx1 nCoV-19–Vaccinated Priority Groups
por: Kaur, Upinder, et al.
Publicado: (2022)

Interdisciplinary Research in Alzheimer’s Disease and the Roles International Societies Can Play
por: Tan, Shawn Zheng Kai, et al.
Publicado: (2021)

A Prospective Observational Study on BBV152 Coronavirus Vaccine Use in Adolescents and Comparison with Adults: Interim Results of the First Real-World Safety Analysis
por: Kaur, Upinder, et al.
Publicado: (2022)

Aging and Neurodegeneration: A Tangle of Models and Mechanisms
por: Chakrabarti, Sasanka, et al.
Publicado: (2016)

Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis
por: Khatana, Chainika, et al.
Publicado: (2020)

Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
por: Ganguly, Upasana, et al.
Publicado: (2021)

New genetic players in late-onset Alzheimer's disease: Findings of genome-wide association studies
por: Misra, Anamika, et al.
Publicado: (2018)

A case of rapidly progressive dementia: A diagnosis not to be missed
por: Das, Pritam, et al.
Publicado: (2019)

The emergence of post-COVID-19 mucormycosis in India: Can we prevent it?
por: Gupta, Amod, et al.
Publicado: (2021)

Global Epidemiology of Mucormycosis
por: Prakash, Hariprasath, et al.
Publicado: (2019)

Short-term follow-up HRCT Chest of COVID-19 survivors and association with persistent dyspnea
por: Kumar, Ishan, et al.
Publicado: (2021)

Pneumococcal disease in India: The dilemma continues
por: Mathew, Joseph L., et al.
Publicado: (2014)

Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
por: Muthu, Valliappan, et al.
Publicado: (2021)

The recent mucormycosis storm over Indian sky
por: Chakrabarti, Arunaloke
Publicado: (2021)

Commentary: Combating COVID-19-associated mucormycosis with limited resources
por: Kim, Usha, et al.
Publicado: (2022)

Budesonide: A promising candidate therapeutic for early COVID-19
por: Patel, Shailesh Kumar, et al.
Publicado: (2021)

MicroRNAs and cardiovascular medicine
por: Kaur, Upinder, et al.
Publicado: (2014)

ANRIL regulates multiple molecules of pathogenetic significance in diabetic nephropathy
por: Sooshtari, Parisa, et al.
Publicado: (2022)

Anti-Sa antibodies: prognostic and pathogenetic significance to rheumatoid arthritis
por: El-Gabalawy, Hani S, et al.
Publicado: (2004)

A Rare Case of Gastrointestinal Mucormycosis
por: Kaur, Jasneet, et al.
Publicado: (2021)

Alteration of Endothelins: A Common Pathogenetic Mechanism in Chronic Diabetic Complications
por: Chakrabarti, Subrata, et al.
Publicado: (2002)

399. Multi-centre Observational Study on Epidemiology, Treatment, and Outcome of Mucormycosis in India
por: Patel, Atul, et al.
Publicado: (2018)

Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study
por: Reddy, Y.Muralidhar, et al.
Publicado: (2022)

COVID-19, mucormycosis, and the cow: Damned lies!
por: Muthu, Valliappan, et al.
Publicado: (2023)

Persistent Health Issues, Adverse Events, and Effectiveness of Vaccines during the Second Wave of COVID-19: A Cohort Study from a Tertiary Hospital in North India
por: Kaur, Upinder, et al.
Publicado: (2022)

Oxidative Stress and Neuroinflammation in Parkinson’s Disease: The Role of Dopamine Oxidation Products
por: Chakrabarti, Sasanka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_emja041ebjicjds932ipbakoov